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Expression and validation of D-erythrulose 1-phosphate dehydrogenase
from Brucella abortus: a diagnostic reagent for bovine brucellosis
Hyungjin Eoh, Bo-Young Jeon, Zhiyeol Kim, Seung-Cheol Kim, Sang-Nae Cho1
Abstract. Brucella abortus is a bacterium of brucellosis causing abortion in cattle. The diagnosis of bovine
brucellosis mainly relies on serologic tests using smooth lipopolysaccharide (S-LPS) from B. abortus. However,
the usefulness of this method is limited by false-positive reactions due to cross-reaction with other Gram-
negative bacteria. In the present study, the eryC gene encoding B. abortus D-erythrulose 1-phosphate
dehydrogenase, which is involved in the erythritol metabolism in virulent B. abortus strain but is absent from a
B. abortus vaccine strain (S19), was cloned. Recombinant EryC was expressed and purified for the evaluation
as a diagnostic reagent for bovine brucellosis. Other B. abortus proteins, Omp16, PP26, and CP39 were also
purified and their seroreactivities were compared. Recombinant EryC, Omp16, PP26, and PP39 were all
reactive to B. abortus-positive serum. The specificity of recombinant Omp16, PP26, CP39, and EryC, were
shown to be approximately 98%, whereas that of B. abortus whole cell lysates was shown to be 95%. The
sensitivity of Omp16, PP26, CP39, and EryC were 10%, 51%, 64%, and 43%, respectively, whereas that of B.
abortus whole cell lysates was 53%. These results suggested that B. abortus EryC would be a potential reagent
for diagnosis for bovine brucellosis as a single protein antigen.
Key words: Brucella abortus; diagnosis; enzyme-linked immunosorbent assay; EryC; smooth lipopolysac-
charide.
Introduction
Brucella abortus (order Rhizobiales, family Brucel-
laceae), the etiologic agent of bovine brucellosis, is
facultative intracellular Gram-negative bacteria.5
Bovine brucellosis primarily affects cattle, and causes
abortion and decreases reproductive efficacy, leading
to economic losses.23 Brucella abortus is also able to
infect human beings, resulting in a public health
problem, especially in developing countries.23
Bovine brucellosis control programs mainly rely on
individual tests and eradication by slaughter. There-
fore, an early and correct diagnosis is essential for the
treatment of bovine brucellosis. Current diagnosis of
bovine brucellosis is mainly based on the detection of
antibodies against B. abortus.42 Thus, various sero-
logic tests are used to diagnose B. abortus-infected
animals as early as possible after infection.1,18 Most
serologic tests, including the standard tube aggluti-
nation test (TAT), are based on the smooth lipopoly-
saccharide (S-LPS) of B. abortus as an antigen.21
Although the S-LPS is widely used, as it is a highly
immunogenic and dominant antigen, it has a critical
defect in that it cross-reacts with other Gram-negative
bacteria, such as Yersinia enterocolitica O:9,15 Esch-
erichia coli O:116/O157,25 Salmonella urbana,26 Fran-
cisella tularensis,2 Vibrio cholerae,17 Pseudomonas
maltophilia,8 and Pasteurella multocida.11 These
cross-reactions generate false-positive results, thus
impeding accurate diagnosis of bovine brucellosis.41
For the purpose of discriminating infected and
vaccinated animals, the B. abortus RB51 vaccine
strain, which expresses weak O-antigen of LPS, has
been practiced.37 However, possibly serologic tests
using the S-LPS could not distinguish between B.
abortus infection and the B. abortus S19 vaccine
strain. This is another significant impediment in
diagnosing bovine brucellosis in countries where
vaccination using B. abortus S19 is practiced.27 To
alleviate this problem, a few B. abortus proteins have
been evaluated as alternate diagnostic reagents for
bovine brucellosis.9,13,14,20,30,39 These include the outer
membrane protein 16 kDa (Omp16),4 the periplasmic
protein 26 kDa (PP26),30 the cytoplasmic protein
39 kDa (CP39),9 and brucellin.19 However, Omp16
showed weak cross-reactivity with phylogenetically
related bacteria such as Ochrobactrum anthropi and
Phyllobacterium rubiacearum6 (also known as Phyllo-
bacterium myrsinacearum), and CP39 showed rela-
tively weak serologic responses.9 Therefore, novel
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B. abortus–specific antigens that are able to induce
high specificity and sensitivity for bovine brucellosis
are needed.7
Brucella abortus has a tropism for reproductive
organs and colonizes in the placenta and fetus of
pregnant cattle, where B. abortus uses the carbon
source erythritol,22 which accumulates in the repro-
ductive organs during the later phases of gesta-
tion.31,34 There are 4 open reading frames (ORFs) in
the ery operon of B. abortus that are involved in
erythritol metabolism. The eryA gene encodes puta-
tive erythritol kinase, the eryB gene encodes an
erythritol phosphate dehydrogenase, the eryC gene
encodes a D-erythrulose 1-phosphate dehydrogenase
(EryC), and the eryD gene encodes a regulator of ery
operon.32 The B. abortus S19 vaccine strain is unable
to use erythritol because the eryC gene is trun-
cated.35,36 Therefore, EryC may constitute a B.
abortus target antigen for diagnostic tests, as it would
distinguish the individuals infected with virulent B.
abortus strain from B. abortus S19 vaccinated
individuals.
In the current study, the B. abortus eryC gene was
cloned, expressed, and purified. Seroreactivity of
recombinant EryC, as a single protein antigen, was
validated as a potential diagnostic reagent for bovine
brucellosis using enzyme-linked immunosorbent as-
say (ELISA). Brucella abortus Omp16, PP26, and
CP39 were also expressed and purified, and their
seroreactivities were compared.
Materials and methods
Bacterial strains and culture conditions
Escherichia coli strains (Top10 and M15)a were used for
cloning and expression of B. abortus genes, respectively,
and were cultured on lysogeny broth (LB) media. The
virulent B. abortus S2308 strain was obtained from the
National Veterinary Research & Quarantine Service (An-
yang, Korea) and was grown in tryptic soy broth (TSB)b
supplemented with 5% bovine serum albumin (BSA)c at
37uC.
Serum samples
A total of 300 serum samples from cattle (100 TAT-
positive and 200 TAT-negative) were provided by the
Gyeonggi-do Veterinary Service (Suwon, Korea). The
TAT-positive serum samples (n 5 100) were used as
positive controls for bovine brucellosis in the validation of
B. abortus proteins. A group of randomly selected TAT-
negative serum samples (n 5 43) was used as negative
controls for recombinant Omp16, PP26, and CP39, and the
other group of TAT-negative serum samples (n 5 93) was
used as negative controls for recombinant EryC. Brucella
abortus whole cell lysates were also used as ELISA antigen
for bovine brucellosis. Control B. abortus–positive and B.
abortus–negative serum samples were provided by the U.S.
Department of Agriculture (USDA; Washington, DC) and
were used for validation of recombinant B. abortus proteins
by Western blot analysis.
PCR amplification and cloning of omp16, pp26, cp39,
and eryC
The sequences of B. abortus S2308 omp16, pp26, cp39,
and eryC genes were obtained from GenBank,d and were
amplified by polymerase chain reaction (PCR) using
oligonucleotide primers harboring appropriate restriction
enzyme sites (Table 1). The PCR-amplified genes were
ligated into the pT7 blue vector,e and their sequences were
confirmed.
Expression and purification of recombinant Omp16, PP26,
CP39, and EryC
All 4 genes were ligated into the pQE30 expression
vectorf after digestion with corresponding restriction
enzymes, affording pQE30::omp16, pQE30::pp26, pQE30::
cp39, and pQE30::eryC. These constructs were then used to
transform E. coli Top10, and then amplified using a
commercial kit.f The expression constructs (pQE30::omp16,
pQE30::pp26, pQE30::cp39, and pQE30::eryC ) were used to
transform E. coli M15 creating M15[pQE30::omp16 ],
M15[pQE30::pp26 ], M15[pQE30::cp39], and M15[pQE30::
eryC ]. Cells were grown to an optical density (OD) of 0.6 at a
wavelength of 600 nm (OD600) in LB media containing 100 mg/
ml ampicillin and 50 mg/ml kanamycin, treated with 0.5 mM of
isopropyl beta-D-thiogalactoside (IPTG) at 37uC for 4 more
hr, recovered by centrifugation, and resuspended in binding
buffer (6.0 M guanidine HCl, 0.1 M sodium phosphate, 0.01 M
Tris-HCl at pH 8.0). The mixture was rocked for 1 hr at room
temperature and centrifuged, and the supernatant was
collected. A high-yield, homogenous preparation of B. abortus
proteins were obtained using a nickel–nitrilotriacetic acid (Ni-
NTA) resin, according to the standard procedures described
by the manufacturer.g Briefly, the supernatants were added to
the equilibrated Ni-NTA agarose in a 1:10 volume ratio. The
bead slurry was then washed with 10 volumes of 50 mM
sodium phosphate, 300 mM NaCl, 10% glycerol, and 20 mM
imidazole (pH 8.0). Recombinant Omp16, PP26, CP39, and
EryC were eluted with 300 mM or 500 mM imidazole in
50 mM sodium phosphate, 300 mM NaCl, and 10% glycerol
(pH 6.0). The eluted proteins were dialyzed with phosphate
buffered saline (PBS; pH 7.4) for 48 hr at 4uC.
Western blot analysis
The recombinant B. abortus proteins were analyzed by a
discontinuous sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS-PAGE), and the expression of the
proteins were visualized by staining with Coomassie
Brilliant Blue 250R. Proteins resolved by SDS-PAGE were
electrophoretically transferred onto a nitrocellulose mem-
brane for Western blot analysis. Membranes were in-
cubated in PBS containing 0.05% Tween 20 and 5% normal
goat serum (PBST-NGS) at room temperature for 1 hr and
then incubated with a 1:300 dilution of B. abortus–positive
and B. abortus–negative sera, provided from USDA, for
1 hr. The membranes were washed 4 times and subsequently
EryC protein for diagnosis of bovine brucellosis 525
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treated with horseradish peroxidase (HRP)-conjugated goat
antibovine immunoglobulin G (IgG) antibodiesh at a
1:10,000 dilution for 1 hr at room temperature. Protein
binding was detected using a commercial immunoblot
system.i
Whole cell lysate preparation
Brucella abortus cells were cultured for 3–4 days in TSB
supplemented with 5% BSA and harvested by centrifuga-
tion at 4,000 rcf for 10 min. To eliminate the residual
media, the recovered bacteria were washed with PBS and
heat inactivated at 120uC for 15 min after adjusting the
number of bacteria at McFarland 3.0 (9 3 108/ml).16 After
centrifugation, the pellet was lyophilized and dissolved in
appropriate buffer for further study.
Indirect enzyme-linked immunosorbent assays
The ELISAs were performed to evaluate the reactivity of
recombinant B. abortus proteins as previously de-
scribed.28 Ninety-six–well enzyme immunoassay (EIA)
platesj were coated overnight with 1.5 mg/ml Omp16,
1.0 mg/ml PP26, 2.0 mg/ml CP39, or 1.5 mg/ml EryC, or
with 2 mg/ml B. abortus whole cell lysates diluted in
100 ml of polycarbonate buffer (pH 9.6) at 4uC. Plates
were then washed and blocked with PBST-NGS. Serum
samples, diluted (1:300) in PBST-NGS, were added to
the wells and incubated for 1 hr at 37uC. The bound
antibodies were detected with HRP-conjugated goat
antibovine IgGh (1:20,000 dilution). After washing 6
times with PBST, an enzyme substrate solution contain-
ing O-phenylenediaminec and hydrogen peroxidase was
added to the plates, and the plates were incubated for
15 min in the dark. The reaction was stopped by the
addition of 2.5 N H2SO4. The absorbance was read at
490 nm using an automatic ELISA plate reader.k Each
serum sample was assayed in duplicate, and the mean
absorbance of carbonate buffer control wells was
subtracted for the mean absorbance of B. abortus
antigen-coated wells. The cutoff was defined as the
mean absorbance value plus 3 standard deviations of the
optical density (OD) values measured in the negative
control samples, as previously described.29 The TAT-
negative serum samples were included as negative
controls. Specificities and sensitivities of ELISA results
using the recombinant B. abortus proteins were calcu-
lated as previously described.12
Statistical analysis
Statistical significances of the specificities and sensitivi-
ties for each protein antigen were determined by the
analysis of variance test using the GraphPad Prism (version
4.0) program,l and differences were considered significant
when P values were ,0.05.
Results
Cloning, expression, and purification of B. abortus omp16,
pp26, cp39, and eryC
The PCR-amplified omp16, pp26, cp39, and eryC
genes were ligated into the pT7 blue vector,
subcloned into the pQE30 vector after enzyme
digestion, and expressed in E. coli M15 cells. All 4
purified recombinant Omp16, PP26, CP39, and
EryC proteins were analyzed by SDS-PAGE, and
the gels were stained with Coomassie Brilliant Blue
250R (Fig. 1A). The molecular masses of Omp16,
PP26, and CP39 were approximately 16, 26, and
39 kDa, respectively. Two protein bands were
observed in the lane of purified EryC (Fig. 1A).
The size of the upper band in SDS-PAGE gel was
approximately 36 kDa, corresponding to the ex-
pected molecular mass of EryC. The unexpected
lower band was shown at the position of approxi-
mately 26 kDa in the lane.
Western blot analysis of recombinant Omp16, PP26, CP39
and EryC
The identification of purified recombinant B.
abortus Omp16, PP26, CP39, and EryC were con-
firmed by Western blot analysis using B. abortus–
positive or B. abortus–negative sera. All 4 B. abortus
proteins were reactive to B. abortus–positive serum
(Fig. 1B), but not reactive to B. abortus–negative
serum (data not shown). Recombinant Omp16 and
CP39 reacted strongly to B. abortus–positive serum,
whereas PP26 did relatively low. Only the upper EryC
protein band reacted to B. abortus–positive serum,
suggesting that the lower EryC protein band contains
no antigenic epitope for generating corresponding
antibody in cattle. These results suggest that all 4
Table 1. Oligonucleotide primers for cloning Brucella abortus genes.*
Primer sequences Restriction enzyme
Omp16 Forward GGATCCATGCGCCGTATCCAGTCGATTGCA BamHI
Reverse AAGCTTACCGTCCGGCCCCGTTGAGAAC HindIII
PP26 Forward GGATCCATGAACACTCGTGCTAGC BamHI
Reverse AAGCTTCATACCCCGGCTATTTAC HindIII
CP39 Forward GGATCCGTGACGTCCGGCGGCGAAG BamHI
Reverse CTGCAGTTATTTTGCGGCTTCAACCGCCAC PstI
EryC Forward GGATCCACAACGCCAATCTAGTTC BamHI
Reverse GCATGCATCTGCCATTGAACGCGG BbuI
* Restriction sites are underlined.
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recombinant B. abortus proteins used in the current
study are reactive to anti–B. abortus sera.
Determination of seroreactivity of recombinant Omp16,
PP26, CP39, and EryC using indirect ELISA
The seroreactivity of recombinant Omp16, PP26,
CP39, and EryC was determined using an indirect
ELISA. A total of 300 serum samples (100 TAT-
positive and 200 TAT-negative) were used as sources
of B. abortus antibody. The 300 serum samples were
prediagnosed using TAT, the standard test of bovine
brucellosis in Korea. The mean absorbance values for
TAT-negative serum samples were measured to be
0.15, 0.14, 0.05, and 0.12 when recombinant Omp16,
PP26, CP39, and EryC were used as antigens,
respectively. The mean absorbance value of B. abortus
whole cell lysates for TAT-negative serum samples
was measured to be 0.20 (Fig. 2). The mean
absorbance value of recombinant CP39 for TAT-
negative serum samples was significantly lower than
those of other proteins and of B. abortus whole cell
lysates (P , 0.001). The mean absorbance value of
recombinant EryC for TAT-negative serum samples
was significantly lower than that of B. abortus whole
cell lysates (P , 0.05). The mean absorbance values
for TAT-positive serum samples were measured to be
0.34, 1.06, 0.36, 0.69, and 0.83 when recombinant
Omp16, PP26, CP39, and EryC and B. abortus whole
cell lysates were used as antigens, respectively. The
mean absorbance value of recombinant PP26 for
TAT-positive serum samples was significantly higher
than those of the other proteins (P , 0.001) and that
of B. abortus whole cell lysates (P , 0.05). The mean
absorbance value of recombinant EryC for TAT-
positive serum samples was higher than that of
Omp16 (P , 0.001) or CP39 (P , 0.001). The
sensitivities for recombinant Omp16, PP26, CP39,
and EryC and for B. abortus whole cell lysates against
TAT-positive serum samples were calculated to be
10%, 51%, 64%, 43%, and 53%, respectively (Table 2).
Although the sensitivity of recombinant CP39 was
highest, the overall absorbance values of positive or
negative samples were relatively lower than those
obtained when other proteins were used as antigens.
The sensitivity of the recombinant PP26 was compa-
rable to that of B. abortus whole cell lysates. The
sensitivity of recombinant EryC was considerably
comparable to that of PP26 or B. abortus whole cell
lysates. The specificities of recombinant Omp16, PP26,
CP39, and EryC were calculated to be 97.7%, 97.7%,
97.7%, and 97.8%, respectively, whereas the specificity
of B. abortus whole cell lysates was calculated to be
94.6%. These results indicate that recombinant PP26
and EryC react strongly toward bovine brucellosis
serum samples and could serve as single diagnostic
protein reagents for bovine brucellosis.
Discussion
Most serologic tests for bovine brucellosis are
based on the detection of antibodies reacting to the
Figure 1. Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) analysis and Western blot analysis of
recombinant Brucella abortus proteins. A, SDS-PAGE analysis of recombinant B. abortus proteins. Lane 1: molecular weight marker;
lane 2: Omp16; lane 3: PP26; lane 4: CP39; and lane 5: EryC. Recombinant B. abortus proteins in SDS-PAGE gels were stained with
Coomassie Brilliant Blue 250R. B, Western blot analysis of the purified proteins was performed using B. abortus–positive serum samples.
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B. abortus S-LPS antigen. Although the S-LPS
antigen is highly immunogenic, it shares epitopes
with other bacterial LPS antigens, possibly leading to
false-positive reactions. The identification of new B.
abortus–specific protein antigens as diagnostic re-
agents is needed to improve the quality of diagnosis
of bovine brucellosis. Although the outer membrane
proteins,4,5,20,38,39 periplasmic proteins,18,30,33 or cyto-
plasmic proteins9,13 of B. abortus have been explored
as a diagnostic reagent for bovine brucellosis, the
serologic test using them is far from ideal.
In the present study, the seroreactivity of a novel B.
abortus protein EryC, using an indirect ELISA with
TAT-positive and TAT-negative serum samples, was
determined. Among B. abortus proteins previously
reported, Omp16 reacted strongly to B. abortus–
positive cattle serum shown by Western blot analysis,
but the sensitivity was relatively low (10%). The
results obtained herein are consistent with previous
reports that B. abortus Omp16 was immunogenic, but
its sensitivity was low due to cross-reactivity with
phylogenetically related other bacteria.7,40 Recombi-
nant CP39 generated low absorbance values in an
indirect ELISA. These results are consistent with a
report performed previously,9 which demonstrated
that the seroreactivity of 39-kDa cytoplasmic protein
was relatively weak. Although recombinant CP39 had
the highest sensitivity (64%), it may not be a good
diagnostic reagent for bovine brucellosis because its
seroreactivity was indistinguishable between TAT-
positive and TAT-negative serum samples. Recombi-
nant PP26, a periplasmic protein, reacted most
strongly to both B. abortus–positive serum samples
shown by Western blot analysis and to TAT-positive
serum samples by an indirect ELISA among the
protein antigens used in the current study. The
highest mean absorbance value was observed in the
ELISA using recombinant PP26 and TAT-positive
serum samples, and the sensitivity of recombinant
PP26 was comparable to that of B. abortus whole cell
lysates. These results are consistent with a previous
report, indicating that the 26-kDa periplasmic protein
had a high agreement with the conventional test for
bovine brucellosis.21
EryC, D-erythrulose 1-phosphate dehydrogenase, is
involved in erythritol metabolism. During recombi-
nant EryC protein purification, 2 bands were
observed on SDS-PAGE gel analysis. An upper band
corresponding to the correct EryC protein size was
reactive but the lower band, which is possibly either a
truncated form of EryC or nonspecifically eluted
protein during purification steps, was not reactive, as
shown by Western blot analysis. Recombinant EryC
had considerably high specificity (97.85%) and
reasonable sensitivity (43%). The mean absorbance
value of recombinant EryC for TAT-negative serum
samples was lower than that of B. abortus whole cell
lysates (P , 0.01) and comparable to that of PP26,
the best protein diagnostic reagent among B. abortus
proteins selected for the current study. The mean
absorbance value of recombinant EryC was quite
high, although it was relatively lower than that of
recombinant PP26 (P , 0.001) and that of B. abortus
whole cell lysates (P , 0.05). The agreement rate of
Figure 2. Seroreactivity of recombinant Omp16, PP26,
CP39, and EryC, and of Brucella abortus whole cell lysates, for
bovine brucellosis. Tube agglutination test (TAT)-positive serum
samples (n 5 100) were used as positive controls for bovine
brucellosis, and TAT-negative serum samples (n 5 43 or 93) were
used as negative controls to evaluate the seroreactivity of
recombinant B. abortus proteins used in the current study using
an indirect enzyme-linked immunosorbent assay with 1.5 mg/ml
Omp16, 1.0 mg/ml PP26, 2.0 mg/ml CP39, or 1.5 mg/ml EryC, or
with 2 mg/ml B. abortus whole cell lysates. Vertical bars represent
mean 6 SD and dotted lines represent cutoff values (0.83, 0.54,
0.14, 0.66, and 0.80 for Omp16, PP26, CP39, and EryC, and for B.
abortus whole cell lysates, respectively). OD 5 optical density.
Table 2. The sensitivity and specificity of the recombinant
Brucella abortus proteins and B. abortus whole cell lysates for
seropositive or seronegative sera determined by tube agglutination
test standard assay.
Sensitivity* Specificity{
Omp16 (10/100) 10% (42/43) 97.7%
PP26 (51/100) 51% (42/43) 97.7%
CP39 (64/100) 64% (42/43) 97.7%
EryC (43/100) 43% (91/93) 97.8%
B. abortus whole
cell lysates (53/100) 53% (88/93) 94.6%
* Sensitivity (%) 5 (number of seropositive serum samples/total
number of tested TAT-positive serum samples) 3 100.
{ Specificity (%) 5 (number of seronegative samples/total
number of tested TAT-negative serum samples) 3 100.
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recombinant EryC was 69.4% for bovine brucellosis,
whereas the agreement rate of recombinant PP26 was
65%. Recombinant EryC may also serve as a
diagnostic reagent for bovine brucellosis in that it is
better to apply to distinguish between cattle carrying
B. abortus S2308 strain and those vaccinated with B.
abortus S19, as S19 is null for eryC.
The sensitivity of B. abortus antigens was more
than 90% for bovine brucellosis in previous re-
ports,3,10,24 but in the current study, the sensitivity
of B. abortus whole cell lysates for TAT-positive
serum samples was approximately 50%. False-posi-
tive reactions may be present in TAT-negative
samples that were identified using S-LPS as a
diagnostic antigen, thus B. abortus–uninfected cattle
might be diagnosed as TAT positive. Other serologic
tests would be required to confirm this issue. In
Korea, bovine brucellosis is prevalent. Therefore, B.
abortus–infected cattle might also be diagnosed as
TAT negative, which could increase the cutoff value
due to high seroreactivity. The present study suggests
that a novel protein of B. abortus, EryC, as well as
PP26 may serve as diagnostic reagents for bovine
brucellosis, as these proteins had a high sensitivity
and specificity for bovine brucellosis. In addition,
EryC may be used to discriminate B. abortus–infected
cattle from B. abortus S19–vaccinated cattle.
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Erratum
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Corrigendum
Stegelmeier, BL, et al.: 2010, Experimental rayless goldenrod (Isocoma pluriflora) toxicosis in goats. J Vet Diagn Invest. 22: 570–577
In the article “Experimental rayless goldenrod (Isocoma pluriflora) toxicosis in goats” by Bryan L. Stegelmeier et al., the 
published mean body weight and the means and statistics of serum biochemistries were carried out on groups of 4 animals, 
not 3, as described in the Material and Methods section. The additional animal in each group was part of an auxiliary physi-
ologic study and though the animals were dosed and treated the same, they were not necropsied and were not included in the 
histologic study. To correct this oversight, the corrected weight and chemistry table (shaded cells indicate corrected numbers) 
are listed below. The differences are minimal and do not alter the conclusions. In addition, reference 7 has been deleted.
Material and Methods: “Fifteen, yearling, female Spanish goats weighing 29.4 ± 3.4 kg (mean ± standard deviation) were 
randomly divided into 5 groups with 3 animals per group.”
References: Reference 7 should be deleted
Corrected Table 1. Selected mean serum biochemical data from groups of 3 goats dosed with rayless goldenrod (Isocoma pluriflora) 
to obtain benzofuran ketone doses of 0, 10, 20, 40, and 60 mg/kg body weight for 7 days.*
Serum result (mean ± standard deviation)
Serum test (reference range†) Dose Day 0 Day 3 Day 6 Day 7
Creatinine kinase (< 350 U/l) 0 226 ± 93 107 ± 6 73 ± 16a 66 ± 30a
 10 226 ± 160 118 ± 8 206 ± 184a 495 ± 623ab
 20 967 ± 1233 306 ± 276 240 ± 113a 497 ± 277ab
 40 125 ± 18 117 ± 24 6,699 ± 5,329b 16,270 ± 11,054b
 60 202 ± 93 202 ± 124 2,987 ± 3,701a 10,433 ± 4,326ab
Cardiac troponin-I (<0.40 U/l‡) 0 <0.02 ± 0.0 <0.02 ± 0.0 <0.02 ± 0.0 <0.02 ± 0.0
 10 <0.02 ± 0.0 <0.02 ± 0.0 <0.02 ± 0.0 <0.02 ± 0.0
 20 <0.02 ± 0.0 0.17 ± 0.26 0.05 ± 0.03 <0.02 ± 0.0
 40 <0.02 ± 0.0 <0.02 ± 0.0 1.98 ± 3.39 1.79 ± 2.97
 60 <0.02 ± 0.0 <0.02 ± 0.0 1.38 ± 2.31 0.13 ± 0.18
Aspartate aminotransferase (<125 U/l) 0 96 ± 7 91 ± 6 83 ± 2a 72 ± 3a
 10 147 ± 69 104 ± 11 89 ± 8a 97 ± 13a
 20 164 ± 82 284 ± 248 293 ± 252ab 376 ± 256a
 40 112 ± 17 102 ± 12 991 ± 184c 3,277 ± 1,556b
 60 96 ± 13 115 ± 31 819 ± 571bc 2,095 ± 1,333b
Alanine aminotransferase (<55 U/l) 0 39 ± 3 37 ± 3 38 ± 0a 43 ± 18a
 10 44 ± 1 42 ± 3 39 ± 2a 37 ± 1a
 20 41 ± 9 57 ± 34 63 ± 38ab 61 ± 25a
 40 46 ± 2 44 ± 4 134 ± 24a 333 ± 127b
 60 40 ± 7 44 ± 5 118 ± 84ab 267 ± 176b
Lactate dehydrogenase (<1,560 U/l) 0 1,061 ± 145 1,075 ± 62 875 ± 213a 573 ± 115a
 10 1,334 ± 668 1,050 ± 223 942 ± 265a 709 ± 182a
 20 1,650 ± 1,546 2,617 ± 2,685 1,185 ± 449a 753 ± 447a
 40 1,054 ± 201 1,162 ± 130 5,996 ± 2,491b 9,891 ± 3,210b
 60 1,026 ± 287 1,277 ± 348 3,623 ± 2,924ab 7,011 ± 5,205a
*Different means (<0.05) between groups are indicated with superscript letters.
†Estimates of normal range were determined as 2 standard deviations from mean values of control goats and pretreatment samples. These ranges are 
probably laboratory and assay specific.
‡Cardiac troponin-I concentrations below detection limits are reported as <0.02 ng/ml.
